2 results
Approved WMOCompleted
The primary objective of this study is to assess the overall safety and tolerability of subcutaneous (SC) trastuzumab using SID (Singel Injection Device) in HER2-positive eBC (early Breast Cancer) patients self-administered at home under supervision…
Approved WMORecruiting
The primary objective of the study is to assess the clinical efficacy of selatogrel when self-administered upon occurrence of symptomssuggestive of an acute myocardial infarction (AMI) in subjects at risk of having a recurrent AMI.The secondary…